Schroder Ventures Life Sciences

Schroder Ventures Life Sciences has announced the expansion of its investment team with the appointment of three new venture partners in London and Boston. Professor Graham Boulnois joins the London team and Joh Borzilleri and Dr Jeffrey Vender will be based in Boston. Boulnois joins from Aventis Pharma AG where he was senior vice president in drug innovation and approval.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland